Mesothelioma Survival

Paul Kraus delivered another inspiring presentation on how he healed his mesothelioma. Every two months, Paul Kraus describes his experience with mesothelioma and answers questions from newly diagnosed mesothelioma patients. If you are a mesothelioma patient or a loved one of a mesothelioma patient and wish to attend a free teleconference with mesothelioma survivor Paul Kraus, the schedule is available at: http://www.survivingmesothelioma.com/speak-to-paul-kraus.cfm or call 619-261-7922 to register.

(PRWEB) August 31, 2006 -- In 1997, Paul Kraus was diagnosed with mesothelioma. The cancer was so widespread that doctors told him there was little hope and he should go home and get his affairs in order. Rather than giving up, Paul created his own path to healing. Today, over nine years later, he continues to enjoy a good quality of life.

Paul wrote an acclaimed book about his diagnosis and healing called: “Surviving Mesothelioma and Other Cancers – A Patient’s Guide.” This book is available on Amazon.com and is the best-selling mesothelioma book in the world. Wanting to inspire more patients, Paul took the unusual step of hosting free bi-monthly teleconferences so that newly diagnosed mesothelioma patients would be able to speak directly to him.

During the most recent conference on August 22nd, Paul described the steps he took to heal his mesothelioma and answered questions from patients and their loved ones. Topics included: new chemotherapy drugs, holistic approaches, vitamins and other supplements, new clinical trials, anti-angiogenesis therapies, mind-body medicine, doctor-patient relationships, and more. While Paul is quick to point out that he is not a doctor and he does not provide medical advice, he inspires patients with his own story of success and survival.

At the end of the teleconference, participants thanked Paul for his words of hope and inspiration and for setting the example that mesothelioma does not have to mean a death sentence.

If you are a mesothelioma patient or a loved one of a mesothelioma patient and wish to attend a free teleconference with mesothelioma survivor Paul Kraus, the schedule is available at: http://www.survivingmesothelioma.com/speak-to-paul-kraus.cfm or call 619-261-7922 to register.

###

Press Contact: Michael Horwin
Company Name: CANCER MONTHLY
Email: email protected from spam bots
Phone: 919-570-8595
Website: http://www.survivingmesothelioma.com/

¶ 9:24 AM 0 comments

BenefitPackages.com Makes Selecting Essential Health Plans Easy

One of the most popular sites for access to health plans, Benefit Packages, provides enhanced services including the offering of new Blue Shield of California Essential Plans for individuals.

(PRWEB) September 1, 2006 -- Benefit Packages a full-service insurance agency, today announced enhancements to their Web site to better able visitors in selecting a health plan that meets their individual or family needs. Benefitpackages.com has been serving Californians for over 15 years and is known as one of the most prominent agencies in the state.

“We want to be able to offer a variety of plans that fit the lifestyle needs and budgets of Californians,” said Larry Hurwitz, Benefit Consultant/Owner of Benefit Packages.com Insurance Agency. “Recently we introduced Blue Shield of California Essential Plans which are popular among young individuals for their affordable premiums and access to valuable and useful benefits.”

Benefitpackages.com offers the most up-to-date plan designs and the ability to pick a plan that meets the varying budget and lifestyle needs of Californians. Enhancements to the Web site include the following functions:
•    Access to the most trusted health insurance carriers in the state
•    Ability to select among the most popular health plans in the market
•    Answers regarding health insurance questions
•    Ability to find a doctor
•    Receive an instant quote
•    Access to excellent, caring customer service (virtual, phone or in person)

For more information on benefitpackages.com or the new individual Essential Plans, underwritten by Blue Shield of California Life & Health Insurance Company, please visit: http://www.benefitpackages.com/essential/index.html or call 1-800-356-3615.

###

Press Contact: Larry Hurwitz
Company Name: Benefitpackages.com
Email: email protected from spam bots
Phone: 1-800-356-3615
Website: http://www.benefitpackages.com/essential/index.html

¶ 3:43 PM 0 comments

Safety Concerns Hit Sales of US Painkillers

Tylenol benefits from safety scares.

(PRWEB) August 19, 2006 -- Sales of products containing acetaminophen have increased in the US after safety concerns hit sales of certain competing analgesics, says the report “Analgesics in United States”, available from Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry.

The 79 page report, written by analysts Euromonitor International, forecasts that acetaminophen will see average growth of nearly 2% a year until 2011, ahead of the rest of the adult analgesics sector which is expected to achieve growth of only 0.8% a year between 2005-2010.

American consumers’ interest in acetaminophen came after questions were raised about the safety of some analgesics. Studies in 2004 linked the use of Vioxx, an anti-inflammatory prescription drug, with an increased risk of heart disease, which led to the product being recalled. Then in April 2005, the US Food and Drug Administration asked Pfizer to recall Bextra, a similar prescription drug, and also warned that OTC non-steroidal anti-inflammatory drugs (NSAIDs), such as Aleve, would need to carry stronger warnings in the future about the risks of heart attacks, strokes, ulcers, internal bleeding and skin reactions.

As acetaminophen is in a separate drug class from anti-inflammatories, such as ibuprofen and naproxen, it mostly escaped public concern over safety and achieved growth of 4.3% between 2004-2005.

The report finds that Tylenol is the most popular brand of acetaminophen with a 14.2% share of the analgesics market. Its manufacturer, McNeil Consumer Healthcare, used the public’s safety concerns as an opportunity to boost the performance of the Tylenol brand by increasing its promotional activity which saw sales of the product increase by almost 18% in 2005.

Despite poor performance for most analgesics, there is also an optimistic outlook for Aspirin, which is forecast to grow by 1.4% per year over 2005-2010. This is due to the widespread use of aspirin for heart attack prevention and consumer trust in the product, as it, too, does not belong to the OTC class of NSAID’s.

“Analgesics in United States” is available in PDF format from Piribo
http://www.piribo.com/search/results.html?k=eur052&x=0&y=0

About Piribo.
Piribo (http://www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.

# # #

Press Contact: Fiona Brown
Company Name: PIRIBO LTD
Email: email protected from spam bots
Phone: 02070607474
Website: http://www.piribo.com/publications/   country/usa_canada/usa/analgesics_united_states.html

¶ 11:36 AM 0 comments

Piribo: Prescription Drugs for Women Could Reach $63bn Within Four Years

Piribo, (http://www.piribo.com) the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called “Women’s Health: Worldwide Prescription Drug Markets” (http://www.piribo.com/search/results.html?k=kal087&x=0&y=0) which predicts that the global market for pharmaceutical treatments for women’s health problems could reach $63 billion by 2010.

(PRWEB) August 18, 2006 -- Piribo, (http://www.piribo.com) the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called “Women’s Health: Worldwide Prescription Drug Markets” (http://www.piribo.com/search/results.html?k=kal087&x=0&y=0) which predicts that the global market for pharmaceutical treatments for women’s health problems could reach $63 billion by 2010.

Unprecedented advancements in the area of women’s health and worldwide recognition of the importance of addressing conditions that overwhelmingly affect women, underscore this growth.

According to the report, 2005 revenues for therapeutics addressing women’s needs, such as autoimmune diseases, cancer, and menopause, among others, exceeded $45 billion. Indeed, from 2000 to 2005, the market grew by 10.5%.

One of the most important developments on the horizon of women’s health is the recent approval of a new cervical cancer vaccine, inaugurating a vaccine market potentially worth several billion dollars a year. The vaccine helps prevent infection from sexually transmitted strains of human papillomavirus (HPV), which causes the cancer. Similarly, the emergence of a possible vaccine-type treatment to prevent AIDS has shown great promise for women around the world.

While sales of hormone replacement drugs fell sharply from 2002 to 2004 on the heels of much publicized reports of the adverse health effects of long term HRT treatment, sales in most other segments have continued to show positive trends, according to the report.

Brief Table of Contents:
Chapter One: Executive Summary
Chapter Two: Introduction and Overview
Chapter Three: Autoimmune Diseases
Chapter Four: Cancer
Chapter Five: Gynecological Infections and Sexually Transmitted Diseases
Chapter Six: Hormone-Related Disorders
Chapter Seven: Osteoporosis
Chapter Eight: Urinary Bladder Disorders
Chapter Nine: Issues and Trends
Chapter Ten: World Market Summary
Chapter Eleven: Competitor Profiles

Women’s Health: Worldwide Prescription Drug Markets includes research and development pipelines; in-depth company profiles; four-region geographic breakdowns; and market size, growth, and share for the following product categories: autoimmune diseases; cancer; gynecological and STDs; hormones; osteoporosis; and urinary disorders. It is available from Piribo.

About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.

###

Press Contact: Fiona Brown
Company Name: PIRIBO LTD
Email: email protected from spam bots
Phone: 02070607474
Website: http://www.piribo.com/

¶ 11:10 AM 0 comments